Decreased levofloxacin susceptibility in Haemophilus influenzae in children, Hong Kong

Emerging Infectious Diseases

Volumn 10, Issue 11, 2004, Pages 1960-1962

  Ho, Pak Leung ^a,b   Chow, Kin Hung ^a   Mak, Cannon C ^a   Tsang, Kenneth W ^a   Lau, Yu Lung ^a   Ho, Alex Y ^a   Lai, Eileen L ^a   Chiu, Susan S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE; LEVOFLOXACIN; NALIDIXIC ACID; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; DISEASE TRANSMISSION; FEMALE; GENE MUTATION; GENE TARGETING; GENETIC SUSCEPTIBILITY; HAEMOPHILUS INFLUENZAE; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; STRAIN DIFFERENCE;

EID: 7644242110     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1011.040055     Document Type: Article

References (15)

1. Barriere SL, Hindler JA. Ciprofloxacin-resistant Haemophilus influenzas infection in a patient with chronic lung disease. Ann Pharmacother. 1993;27:309-10.
2. Ho PL, Cheng VCC. Epidemiology and mechanism of resistance. In: Ronald AR, Low DE, editors. Fluoroquinolone antibiotics: milestones in drug therapy. Berlin: Birkhauser, 2003. p. 49-73.
3. Chiu SS, Ho PL, Chow FKH, Yuen KY, Lau YL. Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrob Agents Chemother. 2001;45:2765-70.
4. Chapin KC, Doern GV. Selective media for recovery of Haemophilus influenzae from specimens contaminated with upper respiratory tract microbial flora. J Clin Microbiol. 1983;17:1163-5.
5. Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Lin G, Felmingham D, et al. Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzae. J Clin Microbiol. 2002;40:3269-76.
6. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing: eleventh informational supplement. Wayne (PA): The Committee; 2001.
7. Biedenbach DJ, Jones RN. Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis. 2003;46:55-61.
8. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
9. Ho PL, Que TL, Tsang DN, Ng TK, Chow KH, Seto WH. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother. 1999;43:1310-3.
10. Ho PL, Yung RW, Tsang DN, Que TL, Ho M, Seto WH, et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicenter study in 2000. J Antimicrob Chemother. 2001;48:659-65.
11. World Health Organization (WHO). The medical impact of the use of antimicrobials in food animals: report and proceedings of a WHO meeting: Berlin, Germany, October 13-17, 1997. Geneva: The Organization; 2001. Document no. WHO/EMC/ZOO/97.4.
12. Darouiche R, Perkins B, Musher D, Hamill R, Tsai S. Levels of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria. J Infect Dis. 1990;162:1124-7.
13. Glode MP, Halsey NA, Murray M, Ballard TL, Barenkamp S. Epiglottitis in adults: association with Haemophilus influenzae type b colonization and disease in children. Pediatr Infect Dis. 1984;3:548-51.
14. Mandell LA, Peterson LR, Wise R, Hooper D, Low DE, Schaad UB, et al. The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? Clin Infect Dis. 2002;35:721-7.
15. Perez-Vazquez M, Roman F, Aracil B, Canton R, Campos J. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations. J Clin Microbiol. 2004;42:1185-91.